Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
3.3M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
494K
-
Shares change
-
+489K
-
Total reported value, excl. options
-
$717K
-
Value change
-
+$710K
-
Number of buys
-
9
-
Number of sells
-
-1
-
Price
-
$1.45
Significant Holders of Aptevo Therapeutics Inc. - Common Stock (APVO) as of Q3 2025
12 filings reported holding APVO - Aptevo Therapeutics Inc. - Common Stock as of Q3 2025.
Aptevo Therapeutics Inc. - Common Stock (APVO) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 494K shares
of 3.3M outstanding shares and own 14.99% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (300K shares), DRW Securities, LLC (131K shares), Virtu Financial LLC (38.3K shares), Focus Partners Wealth (10K shares), OSAIC HOLDINGS, INC. (6.5K shares), UBS Group AG (5.67K shares), Tower Research Capital LLC (TRC) (1.45K shares), SBI Securities Co., Ltd. (570 shares), CITIGROUP INC (74 shares), and BANK OF AMERICA CORP /DE/ (27 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.